Concord Drugs Share Price
Small Cap | Pharmaceuticals and health care | BSE: 538965
₹29.95 
0.17 (0.57 %)
Last Updated: 30 Apr 2025 04:01 PM
BEARISH
Overview
Open (₹) 29.72
High (₹) 29.95
Low (₹) 29.50
Prev. Close (₹) 29.78
Volume 2,388
VWAP (₹) 31.20
ROCE (%) 6.66
Industry P/E 46.55
TTM P/E -748.75
P/B Ratio 0.89
Market Cap (₹) Cr.29.95
Dividend Yield (%)--
EPS (₹) 0.47
ROE1.39%
Sales Growth (%) -13.74
Profit Growth (%)-52.06
Day Range
29.9529.95
52 Week Range
26.1044.96
Historical Returns
Returns (6M)
-20.66 %
Returns (1Y)
-19.19 %
Returns (3Y)
-2.12 %
Returns (5Y)
66.85 %
Returns (6M)
-20.66 %
Returns (1Y)
-19.19 %
Returns (3Y)
-2.12 %
Returns (5Y)
66.85 %
SWOT Analysis
- Company with Low Debt
- Growth in Net Profit Margin (QoQ)
- Growth in Annual Net Profit with increasing Profit Margin (YoY)
- Strong trend indicated by ADX above 25.
Technicals
Technical Rating
BEARISHRSI 48.13
MFI 47.13
ATR 1.95
Commodity Channel Index -70.69
ROC125 -17.35
ROC21 -13.41
Williams %R -80.62
Resistance & Support
| Type | Resistance 1 | Resistance 2 | Resistance 3 | PP | Support 1 | Support 2 | Support 3 |
|---|---|---|---|---|---|---|---|
| Current | 31.62 | 32.50 | 33.01 | 31.11 | 30.23 | 29.72 | 28.84 |
| Week Ago | 32.72 | 35.02 | 36.25 | 31.49 | 29.19 | 27.96 | 25.66 |
| Month Ago | 35.52 | 37.01 | 38.02 | 34.51 | 33.02 | 32.01 | 30.52 |
EMA & SMA
29.95
Current Price
Bullish Moving Averages
0
Bearish Moving Averages
20
5 Day 30.77
9 Day 31.31
10 Day 31.48
12 Day 31.19
14 Day 31.19
20 Day 31.84
26 Day 32.67
50 Day 32.92
100 Day 34.80
200 Day 36.03
Deals & Announcements
Bulk and Block Deals
| Client Name | Deal Type | Action | Date | Avg. Price | Quantity | Exchange |
|---|---|---|---|---|---|---|
| LAKSHMI PRASANNA PALLETI | bulk | Sell | 15th Jan, 2024 | ₹44.63 | 51,994 | BSE |
| MATALIA STOCK BROKING PRIVATE LIMITED | bulk | Sell | 29th Dec, 2023 | ₹57.71 | 59,398 | BSE |
| MATALIA STOCK BROKING PRIVATE LIMITED | bulk | Buy | 29th Dec, 2023 | ₹58.36 | 59,398 | BSE |
| LAKHUBHA SOLANKI | bulk | Sell | 28th Dec, 2023 | ₹51.46 | 51,361 | BSE |
| LAKHUBHA SOLANKI | bulk | Buy | 28th Dec, 2023 | ₹48.10 | 51,361 | BSE |
| SHAHABUDDIN QURRAM MOHAMMED | bulk | Sell | 20th Sept, 2021 | ₹27.21 | 45,930 | BSE |
| MANISH RATILAL GALA | bulk | Sell | 31st Aug, 2021 | ₹26.11 | 40,000 | BSE |
| NAGI REDDY SEELAM | bulk | Buy | 3rd Mar, 2021 | ₹24.99 | 39,716 | BSE |
| MOHIT BUNG | bulk | Sell | 2nd Mar, 2021 | ₹25.01 | 47,381 | BSE |
| NAGI REDDY SEELAM | bulk | Buy | 2nd Mar, 2021 | ₹25.00 | 44,429 | BSE |
Insider Trading
| Date | Name | Action | Avg. Price | Quantity | Deal Value |
|---|---|---|---|---|---|
| 30th Oct, 2023 | S.Nagi Reddy | Acquisition | ₹24.75 | 1,71,133 | BSE |
| 30th Oct, 2023 | S.Manoj Kumar Reddy | Disposal | ₹24.75 | 1,71,133 | BSE |
| 30th Oct, 2023 | S.Manoj Kumar Reddy | Acquisition | ₹24.75 | 1,71,133 | BSE |
| 30th Oct, 2023 | S.Nagi Reddy | Disposal | ₹24.75 | 1,71,133 | BSE |
| 14th Oct, 2023 | S.Nagi Reddy | Disposal | ₹24.75 | 1,71,132 | BSE |
| 14th Oct, 2023 | S.Nagi Reddy | Acquisition | ₹24.75 | 1,71,132 | BSE |
| 14th Oct, 2023 | S.Manoj Kumar Reddy | Disposal | ₹24.75 | 1,71,132 | BSE |
| 14th Oct, 2023 | S.Manoj Kumar Reddy | Acquisition | ₹24.75 | 1,71,132 | BSE |
| 29th Mar, 2023 | S. Manoj Reddy | Disposal | ₹24.75 | 2,85,860 | BSE |
| 29th Mar, 2023 | S. Manoj Reddy | Acquisition | ₹24.75 | 2,85,860 | BSE |
Corporate Actions
No corporate actions available.
Announcements
| Date | Source | Detail |
|---|---|---|
| 15th Apr, 2025 | BSE India | Certificate under Reg 74(5) of SEBI(DP) Regulations, 2018. |
| 17th Mar, 2025 | BSE India | Outcome of Board Meeting |
| 13th Mar, 2025 | BSE India | Concord Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 17/03/2025 ,inter alia, to consider and approve 1. Increase in Authorised Capital\r\n2. Issue of shares on Preferential Allotment\r\n3. Any other matter with the permission of chair |
| 4th Mar, 2025 | BSE India | Concord Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/03/2025 ,inter alia, to consider and approve Increase in Authorised Capital of the company, Fund raising by way of preferential issue of shares and warrants etc and other items. |
| 27th Jan, 2025 | BSE India | Integrated Filing of financials for Quarter Ended 31.12.2024 |
| 7th Jan, 2025 | BSE India | enclosing certificate received from Registrar and Share Transfer Agent |
| 7th Jan, 2025 | BSE India | Concord Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/01/2025 ,inter alia, to consider and approve Un-Audited Financial Results of 31st December 2024 |
| 13th Nov, 2024 | BSE India | Financial Results for Q2 ending Sep 30,2024. |
| 13th Nov, 2024 | BSE India | Financial Results for Q2 ending 30 September 2024 |
| 6th Nov, 2024 | BSE India | Concord Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2024 ,inter alia, to consider and approve Un-audited Financials for quarter ended 30th Sep 2024 |
Board Meetings
| Purpose | Details | Meeting Date | Broadcast Date |
|---|---|---|---|
| Preferential Issue of shares & Others | Inter-alia, to consider 1. Increase in Authorized share Capital. 2. Other business matters. (Revised) | 17th Mar, 2025 | 17th Mar, 2025 |
| Preferential Issue of shares & Others | (Re-scheduled to 17/03/2025) | 17th Mar, 2025 | 13th Mar, 2025 |
| Quarterly Results | -- | 8th Jan, 2025 | 11th Jan, 2025 |
| Quarterly Results | -- | 7th Nov, 2024 | 13th Nov, 2024 |
| Quarterly Results | -- | 6th Aug, 2024 | 9th Aug, 2024 |
| Audited Results | (Revised) | 27th May, 2024 | 30th May, 2024 |
| Audited Results | -- | 25th May, 2024 | 25th May, 2024 |
| Quarterly Results | -- | 7th Feb, 2024 | 13th Feb, 2024 |
| Quarterly Results | -- | 8th Nov, 2023 | 14th Nov, 2023 |
| Quarterly Results | -- | 9th Aug, 2023 | 14th Aug, 2023 |
Share Holding Pattern
| Owner Name | Mar, 2025 | Dec, 2024 | Dec, 2023 | Dec, 2022 | Dec, 2021 |
|---|---|---|---|---|---|
| Promoter Group | 54.39% | 54.39% | 55.41% | 49% | 49% |
| Foreign Institutions + | 0% | 0% | 0% | 0% | 0% |
| Domestic Institutions + | 0% | 0% | 0% | 0% | 0% |
| Government | 0% | 0% | 0% | 0% | 0% |
| Public | 45.61% | 45.61% | 44.59% | 51% | 51% |
| Others | 0% | 0% | 0% | 0% | 0% |
About Concord Drugs
Concord Drugs is a Public Limited Listed company incorporated on 24/04/1995 and has its registered office in the State of Telangana, India. Company’s Corporate Identification Number(CIN) is L24230TG1995PLC020093 and registration number is 020093. Currently company belongs to the Industry of Pharmaceuticals. Company’s Total Operating Revenue is Rs. 43.26 Cr. and Equity Capital is Rs. 10.00 Cr. for the Year ended 31/03/2024.
Parent Organisation
Not Applicable
Founded
1995
Managing Director
Mr. S Nagi Reddy
NSE Symbol
--
Concord Drugs Management
| Name | Designation |
|---|---|
| Mr. S Nagi Reddy | Chairman & Managing Director |
| Mr. S Manoj Kumar Reddy | Whole Time Director |
| Mr. S Koni Reddy | WholeTime Director & CFO |
| Mr. K Ramachandra Reddy | Independent Director |
| Ms. Sumeela Kasu | Independent Director |
| Mr. S Nagavenkata Hareesh | Independent Director |
Peer Comparison
| Stocks | Market Cap | Market Price | 52 Week Low-High |
|---|---|---|---|
| Sun Pharmaceutical Industries | ₹4,39,630.15 | ₹1,832.30  ₹1,805.50(1.48%) | ₹1,376.750 - ₹1,960.200 |
| Divi's Laboratories | ₹1,61,590.72 | ₹6,087.00  ₹6,108.00(-0.34%) | ₹3,725.550 - ₹6,448.750 |
| Cipla | ₹1,25,192.34 | ₹1,550.10 ₹1,541.50(0.56%) | ₹1,310.050 - ₹1,702.000 |
| Torrent Pharmaceuticals | ₹1,12,431.58 | ₹3,322.00 ₹3,322.70(-0.02%) | ₹2,513.050 - ₹3,589.950 |
| Mankind Pharma | ₹1,01,712.98 | ₹2,465.30 ₹2,556.90(-3.58%) | ₹1,910.100 - ₹3,050.000 |
FAQs on Concord Drugs
What is the share price of Concord Drugs?
The share price of Concord Drugs on 30th Apr, 2025 is ₹ 29.95.
What is 52W high and 52W low share price of Concord Drugs?
The highest and lowest 52W share prices of Concord Drugs are ₹ 44.960 and ₹ 26.100
What is the market cap of Concord Drugs?
The market capitalization of Concord Drugs as of 30th Apr, 2025 is ₹ 29.95 Crores
What is the P/E ratio of Concord Drugs?
The current P/E ratio of Concord Drugs as of 30th Apr, 2025 is 46.55
What is the PB ratio of Concord Drugs?
The PB ratio of Concord Drugs as of 30th Apr, 2025 is 0.89
Top Gainers
₹78.00
₹65.00 (0.20%)
₹121.03
₹100.86 (0.20%)
₹13.15
₹11.00 (0.20%)
₹1.88
₹1.57 (0.20%)
Top Losers
₹107.95
₹123.00 (-0.12%)
₹0.50
₹0.56 (-0.11%)
₹24.55
₹28.11 (-0.13%)
₹3.34
₹3.80 (-0.12%)
Market Indices
Sensex
₹80,242.24
₹80,288.38 (0.00%)